Preclinical drug safety and efficacy assessment is crucial, as the results determine whether clinical trials can proceed. However, the success of these evaluations relies on a safe and effective formulation for preclinical tests. The key strength of our platform lies in Langhua Pharmaceutical's extensive experience in preclinical formulation development. Our expertise encompasses preclinical formulation excipients, their safety across different species, and their maximum daily exposure when used in formulations. Additionally, we prioritize the selection of excipients to enhance the formulation’s in vitro and in vivo performance, ensuring optimal results.
